Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jared Knopman

Neurological Surgery New York, NY Medical Doctor

NPI 1699927137 CMS profile 31045

525 E 68Th St # 99, Starr Building 651, New York, NY 10065

Open in the dashboard

General payments

$219,755

595 records reported · program years 2019–2025

Research payments

$800

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$211,793 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jared Knopman of New York, NY is reported in the CMS Open Payments database as having received $219,755 across 595 general payments and $800 in research payments paid to them. Separately, studies naming them as principal investigator received $211,793 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $61,781 52
2024 General $42,683 72
2023 General $26,189 70
2022 General $33,148 121
2021 General $23,450 92
2020 General $18,182 67
2019 General $14,323 121
2019 Research $800 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jared Knopman
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Jared Knopman were reported at $61,781. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Jared Knopman Neurological Surgery median Middle half National median
2019 $14,323 $582 $138–$3,006 $163
2020 $18,182 $294 $76–$2,174 $114
2021 $23,450 $387 $105–$2,432 $132
2022 $33,148 $542 $139–$2,989 $149
2023 $26,189 $534 $145–$2,697 $160
2024 $42,683 $574 $155–$3,046 $164
2025 $61,781 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $85,369 179 payments
  2. Medtronic, Inc. $57,972 154 payments
  3. MicroVention, Inc. $41,529 70 payments
  4. Balt USA, LLC $14,426 27 payments
  5. Penumbra, Inc. $7,769 80 payments
  6. Medtronic USA, Inc. $6,586 39 payments
  7. phenox Inc. $3,762 7 payments
  8. Boston Scientific Corporation $1,305 18 payments
  9. Imperative Care, INc $259 4 payments
  10. Globus Medical, Inc. $250 2 payments
  11. Other $527 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $120,463 31 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $48,990 24 payments
  3. Travel and Lodging $33,307 97 payments
  4. Food and Beverage $16,996 443 payments
Products named General payments · program years 2019–2025
  1. SURPASS EVOLVE $39,298 45 payments
  2. ONYX 18 $35,066 28 payments
  3. TGS $20,800 1 payment
  4. TARGET $20,631 29 payments
  5. WEB Aneurysm Embolization System Neurological Product $11,713 8 payments
  6. Pipeline Flow Diversion $11,202 51 payments
  7. WEB ANEURYSM EMBOLIZATION SYSTEM Neurological Product $8,522 12 payments
  8. Pipeline Flow Diversion $6,065 16 payments
  9. NEUROFORM ATLAS $4,113 24 payments
  10. Avenir Coil $3,567 5 payments
  11. Other $31,598 386 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic USA, Inc. $800 1 payment

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$263,445

Medicare's payments for the services billed

Medicare patients

228

Average age 76

Services billed

1,172

107 women, 121 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Ischemic heart disease 40%
Diabetes 32%
Atrial fibrillation 29%
Chronic kidney disease 25%
Cancer 25%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

596 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record